Pancreatic Cancer Research

ResearcherChinese Academy of Medical Sciences & Peking Union Medical CollegeNo recent work listed

Pingping Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-0196-7913; OpenAlex author ID A5100666029. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2015: 1 paper · 2016: 1 paper · 2017: 1 paper

Papers 3

  1. The lncRNA MALAT1 acts as a competing endogenous RNA to regulate KRAS expression by sponging miR-217 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41598-017-05274-4↗
  2. KRAS-related noncoding RNAs in pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.cdtm.2016.11.012↗
  3. Elevated miR-483-3p expression is an early event and indicates poor prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s13277-015-3690-x↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jie Chen · 2 shared papers, 2016–2017 · strength 0.14
  2. Shuangni Yu · 2 shared papers, 2015–2016 · strength 0.11
  3. Wei‐Min Tong · 1 shared paper, 2017 · strength 0.08
  4. Xianglan Jin · 1 shared paper, 2016 · strength 0.07
  5. Yihui Ma · 1 shared paper, 2016 · strength 0.07
  6. Cuiping Wang · 1 shared paper, 2015 · strength 0.05
  7. Jie Chen · 1 shared paper, 2015 · strength 0.05
  8. Huanwen Wu · 1 shared paper, 2015 · strength 0.05
  9. Yunxiao Meng · 1 shared paper, 2015 · strength 0.05
  10. Yang Sun · 1 shared paper, 2015 · strength 0.05
  11. Mingyang Liu · 1 shared paper, 2015 · strength 0.05
  12. Li Zhang · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.